Bladder cancer

Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

Volumn , Issue , 2017, Pages 977-996

  Silverman, Debra T ^a   Koutros, Stella ^a   Figueroa, Jonine D ^b   Prokunina Olsson, Ludmila ^a   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bladder; Bladder cancer; Cigarette; Nonsmoker; Smoking

Indexed keywords

EID: 85051032028     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oso/9780190238667.003.0052     Document Type: Chapter

References (215)

1. Abdulamir AS, Hafidh RR, Kadhim HS, and Abubakar F. 2009. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res, 28, 27 .PMCID: PMC2650688.
2. Abol-Enein H. 2008. Infection: is it a cause of bladder cancer? Scand J Urol Nephrol Suppl, 218, 79-84 .PMID: 18815920.
3. AICR. 2007. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research.
4. AICR. 2015. Continuous update project report: diet, nutrition, physical activity, and bladder cancer. Washington, DC: World Cancer Research Fund International/American Institute for Cancer Research.
5. Alguacil J, Kogevinas M, Silverman DT, et al. 2011. Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis, 32(6), 843-847 .PMCID: PMC3106435.
6. Amaral AF, Cantor KP, Silverman DT, and Malats N. 2010. Selenium and bladder cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 19(9), 2407-2415 .PMID: 20807831.
7. Amaral AF, Mendez-Pertuz M, Munoz A, et al. 2012. Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst, 104(24), 1897-1904 .PMCID: PMC3525815.
8. Amr S, Dawson R, Saleh DA, et al. 2015. Pesticides, gene polymorphisms, and bladder cancer among Egyptian agricultural workers. Arch Environ Occup Health, 70(1), 19-26 .PMCID: PMC4018465.
9. Andreotti G, Karami S, Pfeiffer RM, et al. 2014. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Epigenetics, 9(3), 404-415 .PMCID: PMC4053459.
10. Baack Kukreja JE, Scosyrev E, Brasacchio RA, et al. 2014. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer. BJU Int, 114(6), 844-851 .PMID: 26010047.
11. Baris D, Karagas MR, Koutros S, et al. 2013. Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Int J Cancer, 132(1), 162-173 .PMCID: PMC3951299.
12. Baris D, Karagas MR, Verrill C, et al. 2009. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst, 101(22), 1553-1561 .PMCID: PMC2778671.
13. Baris D, Waddell R, Beane Freeman LE, et al. 2016. Elevated bladder cancer in Northern New England: The role of drinking water and arsenic. J Natl Cancer Inst, 108(9), djw099 .PMID:27140955.
14. Bates MN, Smith AH, and Cantor KP. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol, 141(6), 523-530 .PMID: 7900719.
15. Beane Freeman LE, Karagas MR, Baris D, et al. 2015. Is the inverse association between selenium and bladder cancer due to confounding by smoking? Am J Epidemiol, 181(7), 488-495 .PMCID: PMC4447815.
16. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. 2006. The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control, 17(10), 1305-1309 .PMID: 17111263.
17. Braver DJ, Modan M, Chetrit A, Lusky A, and Braf Z. 1987. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst, 78(3), 437-440 .PMID: 3469457.
18. Bray F, Ren JS, Masuyer E, and Ferlay J. 2013. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132(5), 1133-1145 .PMID: 22752881.
19. Brennan P, Bogillot O, Cordier S, et al. 2000. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer, 86(2), 289-294 .PMID: 10738259.
20. Brinkman MT, Karagas MR, Zens MS, et al. 2010. Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control, 21(4), 609-619 .PMCID: PMC2839516.
21. Brown LM, Zahm SH, Hoover RN, and Fraumeni JF, Jr. 1995. High bladder cancer mortality in rural New England (United States): an etiologic study. Cancer Causes Control, 6(4), 361-368 .PMID: 7548724.
22. Cantor KP, Hoover R, Hartge P, et al. 1987. Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst, 79(6), 1269-1279 .PMID: 3480378.
23. Cantor KP, Villanueva CM, Silverman DT, et al. 2010. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect, 118(11), 1545-1550 .PMCID: PMC2974691.
24. Cappellen D, De Oliveira C, Ricol D, et al. 1999. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet, 23(1), 18-20 .PMID: 10471491.
25. Carreon T, Hein MJ, Hanley KW, Viet SM, and Ruder AM. 2014. Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant. Occup Environ Med, 71(3), 175-182 .PMCID: PMC4548974.
26. Castano-Vinyals G, Talaska G, Rothman N, et al. 2007. Bulky DNA adduct formation and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev, 16(10), 2155-2159 .PMID: 17932365.
27. Castelao JE, Yuan JM, Gago-Dominguez M, et al. 2000. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer, 82(7), 1364-1369 .PMCID: PMC2374480.
28. Catsburg CE, Gago-Dominguez M, Yuan JM, et al. 2014. Dietary sources of N- nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer, 134(1), 125-135 .PMID: 23775870.
29. Chavan S, Bray F, Lortet-'Tieulent J, Goodman M, and Jemal A. 2014. International variations in bladder cancer incidence and mortality. Eur Urol, 66(1), 59-73 .PMID: 24451595.
30. Choi W, Porten S, Kim S, et al. 2014. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell, 25(2), 152-165 .PMCID: PMC4011497.
31. Chung CJ, Lee HL, Yang HY, et al. 2011. Low ratio of 4- (methylnitrosa- mino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk. Sci Total Environ, 409(9), 1638-1642 .PMID: 21334728.
32. Chung D, Yang C, Li C, Gelernter J, and Zhao H. 2014. GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation. PLoS Genet, 10(11), e1004787 .PMCID: PMC4230845.
33. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, and Large MC. 2014. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer, 120(4), 555-561 .PMCID: PMC3916781.
34. Colmers IN, Majumdar SR, Yasui Y, et al. 2013. Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study. Diabetes Care, 36(10), 3070-3075 .PMCID: PMC3781560.
35. Colt JS, Friesen MC, Stewart PA, et al. 2014. A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men. Occup Environ Med, 71(10), 667-674 .PMCID: PMC4690539.
36. Costet N, Villanueva CM, Jaakkola JJ, et al. 2011. Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies. Occup Environ Med, 68(5), 379-385 .PMID: 21389011.
37. Cumberbatch MG, Rota M, Catto JW, and La Vecchia C. 2016. The role of Tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol, 70(3), 458-466 .PMID: 26149669.
38. Damrauer JS, Hoadley KA, Chism DD, et al. 2014. Intrinsic subtypes of high- grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A, 111(8), 3110-3115 .PMCID: PMC3939870.
39. Daugherty SE, Lacey JV, Jr., Pfeiffer RM, et al. 2013. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer, 133(2), 462-472 .PMCID: PMC3646919.
40. Daugherty SE, Pfeiffer RM, Sigurdson AJ, et al. 2011. Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. Am J Epidemiol, 173(7), 721-730 .PMCID: PMC3105281.
41. Davis-Dao CA, Henderson KD, Sullivan-Halley J, et al. 2011. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev, 20(6), 1156-1170 .PMCID: PMC3312020.
42. Dietrich K, Demidenko E, Schned A, et al. 2011. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and metaanalysis. Eur J Cancer, 47(4), 592-599 .PMCID: PMC3042804.
43. Dunham LJ, Rabson AS, Stewart HL, Frank AS, and Young JL. 1968. Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst, 41(3), 683-709 .PMID: 5677316.
44. Espejo-Herrera N, Cantor KP, Malats N, et al. 2015. Nitrate in drinking water and bladder cancer risk in Spain. Environ Res, 137, 299-307 .PMID: 25601732.
45. Fernandez MI, Gong Y, Ye Y, et al. 2013. gamma-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Carcinogenesis, 34(11), 2543-2547 .PMCID: PMC3810842.
46. Figueroa JD, Han SS, Garcia-Closas M, et al. 2014a. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis, 35(8), 1737-1744 .PMCID: PMC4123644.
47. Figueroa JD, Koutros S, Colt JS, et al. 2015. Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. J Natl Cancer Inst, 107(11), djv223 .PMCID: PMC4675099.
48. Figueroa JD, Middlebrooks CD, Banday AR, et al. 2016. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet, 25(6), 1203-1214 .PMID: 26732427.
49. Figueroa JD, Ye Y, Siddiq A, et al. 2014b. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet, 23(5), 1387-1398 .PMCID: PMC3919005.
50. Fletcher O, Easton D, Anderson K, et al. 2004. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst, 96(5), 357-363 .PMID: 14996857.
51. Fortuny J, Kogevinas M, Garcia-Closas M, et al. 2006. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev, 15(9), 1696-1702 .PMID: 16985032.
52. Fortuny J, Kogevinas M, Zens MS, et al. 2007. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol, 7, 13 .PMCID: PMC2018698.
53. Freedman ND, Abnet CC, Caporaso NE, et al. 2015. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking- related cancers among the women and men of the NIH-AARP cohort. Int J Epidemiol. 45(3), 846-856 .PMCID: PMC5005940.
54. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, and Abnet CC. 2011. Association between smoking and risk of bladder cancer among men and women. JAMA, 306(7), 737-745 .PMCID: PMC3441175.
55. Friesen MC, Costello S, and Eisen EA. 2009. Quantitative exposure to metalworking fluids and bladder cancer incidence in a cohort of autoworkers. Am J Epidemiol, 169(12), 1471-1478 .PMID: 19414495.
56. Fu YP, Kohaar I, Moore LE, et al. 2014. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res, 74(20), 5808-5818 .PMCID: PMC4203382.
57. Fu YP, Kohaar I, Rothman N, et al. 2012. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A, 109(13), 4974-4979 .PMCID: PMC3324016.
58. Garcia-Closas M, Hein DW, Silverman D, et al. 2011a. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet Genomics, 21(4), 231-236 .PMCID: PMC3003749.
59. Garcia-Closas M, Rothman N, Figueroa JD, et al. 2013. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res, 73(7), 2211-2220 .PMID: 23536561.
60. Garcia-Closas M, Ye Y, Rothman N, et al. 2011b. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet, 20(21), 4282-289 .PMCID: PMC3188994.
61. Garcia-Closas R, Garcia-Closas M, Kogevinas M, et al. 2007. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer, 43(11), 1731-1740 .PMID: 17596928.
62. Gonzalez CA, Errezola M, Izarzugaza I, et al. 1991. Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer, 27(4), 498-500 .PMID: 1827729.
63. Goossens ME, Zeegers MP, Bazelier MT, et al. 2015. Risk of bladder cancer in patients with diabetes: a retrospective cohort study. BMJ Open, 5(6), e007470 .PMCID: PMC4458630.
64. Grant EJ, Ozasa K, Preston DL, et al. 2012. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors. Radiat Res, 178(1), 86-98 .PMID: 22631857.
65. Gripp KW. 2005. Tumor predisposition in Costello syndrome. Am J Med Genet C Semin Med Genet, 137C(1), 72-77 .PMID: 16010679.
66. Grotenhuis AJ, Dudek AM, Verhaegh GW, et al. 2014. Prognostic relevance of urinary bladder cancer susceptibility loci. PLoS One, 9(2), e89164 .PMCID: PMC3934869.
67. Gu J, Horikawa Y, Chen M, Dinney CP, and Wu X. 2008. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev, 17(9), 2445-2450 .PMID: 18768515.
68. Guo G, Sun X, Chen C, et al. 2013. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet, 45(12), 1459-1463 .PMID: 24121792.
69. Hall P. 2008. Radiation-associated urinary bladder cancer. Scand J Urol Nephrol Suppl, 218, 85-88 .PMID: 18815921.
70. Hamann D, Yazar K, Hamann CR, Thyssen JP, and Liden C. 2014. p- Phenylenediamine and other allergens in hair dye products in the United States: a consumer exposure study. Contact Dermatitis, 70(4), 213-218 .PMID: 24628345.
71. Harling M, Schablon A, Schedlbauer G, Dulon M, and Nienhaus A. 2010. Bladder cancer among hairdressers: a meta-analysis. Occup Environ Med, 67(5), 351-358 .PMCID: PMC2981018.
72. Hartge P, Harvey EB, Linehan WM, et al. 1990. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst, 82(20), 1636-1640 .PMID: 2213906.
73. He H, and Shui B. 2014. Folate intake and risk of bladder cancer: a metaanalysis of epidemiological studies. Int J Food Sci Nutr, 65(3), 286-292 .PMID: 24328495.
74. Hedegaard J, Lamy P, Nordentoft I et al. 2016. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. Cancer Cell, 30(1):27-42 .PMID:27321955.
75. Hemminki K, Bermejo JL, Ji J, and Kumar R. 2011. Familial bladder cancer and the related genes. Curr Opin Urol, 21(5), 386-392 .PMID: 21738036.
76. Henning A, Wehrberger M, Madersbacher S et al. 2013. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int, 112(1), 68-73 .PMID: 23320798.
77. Hicks RM. 1983. The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents. ProcNutr Soc, 42(1), 83-93 .PMID: 6220411.
78. Hirao S, Hirao T, Marsit CJ et al. 2005. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer, 104(9), 1918-1923 .PMID: 16149093.
79. Hoadley KA, Yau C, Wolf DM, et al. 2014. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 158(4), 929-944 .PMCID: PMC4152462.
80. Howe GR, Burch JD, Miller AB, et al. 1980. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst, 64(4), 701-713 .PMID: 6928984.
81. Huang YK, Huang YL, Hsueh YM, et al. 2008. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control, 19(8), 829-839 .PMID: 18351295.
82. IARC. 2010. Some aromatic amines, organic dyes, and related exposures. IARC Monogr Eval Carcinog Risks Hum, 99, 1-658 .PMID: 21528837.
83. IARC. 2012a. Chemical agents and related occupations. IARC Monogr Eval Carcinog Risks Hum, 100(Pt F), 93-100 .PMID: 23189753.
84. IARC. 2012b. Arsenic, metals, fibers and dusts. IARC Monogr Eval Carcinog Risks Hum, 100(Pt C), 11-465 .PMID: 23189751
85. IARC. 2014. Trichloroethylene, tetrachloroethylene, and some other chlorinated agents. IARC Monogr Eval Carcinog Risks Hum, 106, 1-512 .PMID: 26214861.
86. Jhamb M, Lin J, Ballow R, et al. 2007. Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control, 18(8), 839-845 .PMID: 17593531.
87. Jiang X, Castelao JE, Groshen S, et al. 2009. Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer, 100(5), 834-839 .PMCID: PMC2653778.
88. Jiang X, Castelao JE, Groshen S, et al. 2008. Water intake and bladder cancer risk in Los Angeles County. Int J Cancer, 123(7), 1649-1656 .PMID: 18623082.
89. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, and Yu MC. 2007. Environmental Tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res, 67(15), 7540-7545 .PMID: 17671226.
90. Johansson GM, Jonsson BA, Axmon A, et al. 2015. Exposure of hairdressers to ortho- and meta-toluidine in hair dyes. Occup Environ Med, 72(1), 57-63 .PMCID: PMC4283615.
91. Jones RR, Weyer PJ, DellaValle CT, et al. 2016. Nitrate from drinking water and diet and bladder cancer among postmenopausal women in Iowa. Environ Health Perspect, 124(11), 1751-1758 .PMID: PMC5089883.
92. Kabat GC, Kim MY, Luo J, et al. 2013. Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women. Eur J Cancer Prev, 22(5), 409-416 .PMID: 23442343.
93. Kadlubar FF, Dooley KL, Teitel CH, et al. 1991. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res, 51(16), 4371-4377 .PMID: 1868460.
94. Kamangar F, Shakeri R, Malekzadeh R, and Islami F. 2014. Opium use: an emerging risk factor for cancer? Lancet Oncol, 15(2), e69-77 .PMID: 24480557.
95. Kang HW, Song PH, Ha YS, et al. 2013. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients. Eur J Cancer, 49(14), 3010-3019 .PMID: 23810248.
96. Kantor AF, Hartge P, Hoover RN, and Fraumeni JF, Jr. 1985. Familial and environmental interactions in bladder cancer risk. Int J Cancer, 35(6), 703-706 .PMID: 4008097.
97. Kantor AF, Hartge P, Hoover RN, et al. 1984. Urinary tract infection and risk of bladder cancer. Am J Epidemiol, 119(4), 510-515 .PMID: 6711540.
98. Karagas MR, Tosteson TD, Morris JS, et al. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control, 15(5), 465-472 .PMID: 15286466.
99. Keimling M, Behrens G, Schmid D, Jochem C, and Leitzmann MF. 2014. The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer, 110(7), 1862-1870 .PMCID: PMC3974090.
100. Kelsey KT, Hirao T, Hirao S, et al. 2005. TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int J Cancer, 117(3), 370-375 .PMID: 15906354.
101. Khaled H. 2013. Schistosomiasis and cancer in egypt: review. J Adv Res, 4(5), 461-466 .PMCID: PMC4293882.
102. Kiemeney LA, Sulem P, Besenbacher S, et al. 2010. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet, 42(5), 415-419 .PMCID: PMC2923020.
103. Kiemeney LA, Thorlacius S, Sulem P, et al. 2008. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet, 40(11), 1307 PMID: 18794855.
104. Kjaer SK, Knudsen JB, Sorensen BL, and Moller Jensen O. 1989. The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol, 28(5), 631-636 .PMID: 2686724.
105. Knowles MA and Hurst CD. 2015. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer, 15(1), 25-41 .PMID: 25533674.
106. Kogevinas M, Fernandez F, Garcia-Closas M, et al. 2006. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer, 42(10), 1448-1454 .PMID: 16740387.
107. Kohaar I, Porter-Gill P, Lenz P, et al. 2013. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst, 105(1), 69-73 .PMCID: PMC3536639.
108. Koutros S, Baris D, Fischer A, et al. 2013. Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer, 133(12), 3008-3013 .PMCID: PMC3797230.
109. Koutros S, Silverman DT, Alavanja MC, et al. 2016. Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol, 45(3), 792-805 .PMID: PMC5005942.
110. Koutros S, Silverman DT, Baris D, et al. 2011. Hair dye use and risk of bladder cancer in the New England bladder cancer study. Int J Cancer, 129(12), 2894-2904 .PMCID: PMC3203248.
111. Kurttio P, Pukkala E, Kahelin H, Auvinen A, and Pekkanen J. 1999. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect, 107(9), 705-710 .PMCID: PMC1566462.
112. La Vecchia C, Lucchini F, Negri E, and Levi F. 1999. Urinary bladder cancer death rates in Europe. Ann Oncol, 10(12), 1529-1530 .PMID: 10643550.
113. Lenz P, Pfeiffer R, Baris D, et al. 2012. Cell-cycle control in urothelial carcinoma: large-cale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev, 21(9), 1555-1564 .PMCID: PMC3480660.
114. Lesseur C, Gilbert-Diamond D, Andrew AS, et al. 2012. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic- related bladder cancer in New Hampshire. Toxicol Lett, 210(1), 100-106 .PMCID: PMC3374400.
115. Lewis JD, Habel LA, Quesenberry CP, et al. 2015. Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes. JAMA, 314(3), 265-277. PMID: 26197187.
116. Li F, An S, Hou L, et al. 2014. Red and processed meat intake and risk of bladder cancer: a meta-analysis. Int J Clin Exp Med, 7(8), 2100-2110 .PMCID: PMC4161554.
117. Liao Y, Huang JL, Qiu MX, and Ma ZW. 2015. Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis. Tumour Biol, 36(3), 1567-1572 .PMID: 25359617.
118. Lin J, Dinney CP, Grossman HB, and Wu X. 2006a. Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case- control study. Cancer Epidemiol Biomarkers Prev, 15(9), 1746-1749 .PMID: 16985040.
119. Lin J, Spitz MR, Dinney CP, et al. 2006b. Bladder cancer risk as modified by family history and smoking. Cancer, 107(4), 705-711 .PMID: 16845665.
120. Mao Q, Lin Y, Zheng X, et al. 2010. A meta-analysis of alcohol intake and risk of bladder cancer. Cancer Causes Control, 21(11), 1843-1850 .PMID: 20617375.
121. Marsit CJ, Karagas MR, Danaee H, et al. 2006. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis, 27(1), 112-116 .PMID: 15987713.
122. Matsuda K, Takahashi A, Middlebrooks CD, et al. 2015. Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum Mol Genet, 24(4), 1177-1184 .PMID: 25281661.
123. McCredie M, Stewart JH, Ford JM, and MacLennan RA. 1983. Phenacetin- containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol, 55(2), 220-224 .PMID: 6839099.
124. McDonald DF, and Lund RR. 1954. The role of the urine in vesical neoplasm. I. Experimental confirmation of the urogenous theory of pathogenesis. J Urol, 71(5), 560-570 .PMID: 13152884.
125. Menashe I, Figueroa JD, Garcia-Closas M, et al. 2012. Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One, 7(1), e29396 .PMCID: PMC3251580.
126. Michaud DS, Kogevinas M, Cantor, et al. 2007. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect, 155(11), 1569-1572 .PMCID: PMC2072844.
127. Michaud DS, Spiegelman D, Clinton SK, et al. 1999. Fluid intake and the risk of bladder cancer in men. N Engl J Med, 340(18), 1390-1397 .PMID: 10228189.
128. Middlebrooks CD, Banday AR, Matsuda K, et al. 2016. Association of germ- line variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat Genet, 48(11), 1330-1338.
129. Mills PK, Beeson WL, Phillips RL, and Fraser GE. 1991. Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol, 133(3), 230-239 .PMID: 2000840.
130. Moore LE, Baris DR, Figueroa JD, et al. 2011. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis, 32(2), 182-189 .PMCID: PMC3026839.
131. Moyer VA. 2011. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 155(4), 246-251 .PMID: 21844550.
132. Murta-Nascimento C, Silverman DT, Kogevinas M, et al. 2007. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev, 16(8), 1595-1600 .PMID: 17684133.
133. Nekolla EA, Walsh L, and Spiess H. 2010. Incidence of malignant diseases in humans injected with radium-224. Radiat Res, 174(3), 377-386 .PMID: 20726727.
134. Nickerson ML, Dancik GM, Im KM, et al. 2014. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer. Clin Cancer Res, 20(18), 4935-4948 .PMCID: PMC4166537.
135. Nielsen ME, Smith AB, Meyer AM, et al. 2014. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer, 120(1), 86-95 .PMCID: PMC3964001.
136. Nohynek GJ, Skare JA, Meuling WJ, et al. 2015. Human systemic exposure to [(1)(4)C]-paraphenylenediamine-containing oxidative hair dyes: absorption, kinetics, metabolism, excretion and safety assessment. Food Chem Toxicol, 81, 71-80 .PMID: 25846501.
137. Ouerhani S, Rouissi K, Kourda N, et al. 2009. Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors. Cancer Invest, 27(10), 998-1007 .PMID: 19909015.
138. Oyasu R, Hirao Y, and Izumi K. 1981. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res, 41(2), 478-481. pMiD: 7448795.
139. Parkash O, and Kiesswetter H. 1976. The role of urine in the etiology of cancer of the urinary bladder. Urol Int, 31(5), 343-348 .PMID: 1006869.
140. Peters S, Talaska G, Jonsson BA, Kromhout H, and Vermeulen R. 2008. Polycyclic aromatic hydrocarbon exposure, urinary mutagenicity, and DNA adducts in rubber manufacturing workers. Cancer Epidemiol Biomarkers Prev, 17(6), 1452-1459 .PMID: 18559561.
141. Piper JM, Matanoski GM, and Tonascia J. 1986. Bladder cancer in young women. Am J Epidemiol, 123(6), 1033-1042 .PMID: 3706274.
142. Pira E, Piolatto G, Negri E, et al. 2010. Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up. J Natl Cancer Inst, 102(14), 1096-1099 .PMID: 20548022.
143. Pommer W, Bronder E, Klimpel A, et al. 1999. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant, 14(12), 2892-2897 .PMID: 10570093.
144. Porru S, Pavanello S, Carta A, et al. 2014. Complex relationships between occupation, environment, DNA adducts, genetic polymorphisms and bladder cancer in a case-control study using a structural equation modeling. PLoS One, 9(4), e94566 .PMCID: PMC3983188.
145. Purdue MP and Silverman DT. 2016. Clearing the air: summarizing the smoking-related relative risks of bladder and kidney cancer. Eur Urol, 70(3), 467-468 .PMID: 27130147.
146. Radosavljevic V, Jankovic S, Marinkovic J, and Djokic M. 2003. Fluid intake and bladder cancer: a case control study. Neoplasma, 50(3), 234-238 .PMID: 12937859.
147. Rafnar T, Sulem P, Stacey SN, et al. 2009. Sequence variants at the TERT- CLPTM1L locus associate with many cancer types. Nat Genet, 41(2), 221-227 .PMID: 19151717.
148. Rafnar T, Sulem P, Thorleifsson G, et al. 2014. Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum Mol Genet, 23(20), 5545-5557 .PMID: 24861552.
149. Rafnar T, Vermeulen SH, Sulem P, et al. 2011. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet, 20(21), 4268-4281 .PMCID: PMC3188988.
150. Reynolds LM, Wan M, Ding J, et al. 2015. DNA methylation of the aryl hydrocarbon receptor repressor associations with cigarette smoking and subclinical atherosclerosis. Circ Cardiovasc Genet, 8(5), 707-716 .PMCID: PMC4618776.
151. Romanenko A, Morimura K, Wanibuchi H, et al. 2003. Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation. Cancer Sci, 94(4), 328-333 .PMID: 12824899.
152. Ros MM, Gago-Dominguez M, Aben KK, et al. 2012. Personal hair dye use and the risk of bladder cancer: a case-control study from The Netherlands. Cancer Causes Control, 23(7), 1139-1148 .PMCID: PMC3369132.
153. Roswall N, Freisling H, Bueno-de-Mesquita HB, et al. 2014. Anthropometric measures and bladder cancer risk: a prospective study in the EPIC cohort. Int J Cancer, 135(12), 2918-2929 .PMID: 24771290.
154. Rothman N, Garcia-Closas M, Chatterjee N, et al. 2010. A multi-stage genome- wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet, 42(11), 978-984 .PMCID: PMC3049891.
155. Rothman N, Talaska G, Hayes RB, et al. 1997. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol Biomarkers Prev, 6(12), 1039-1042 .PMID: 9419400.
156. Rowland RG, Henneberry MO, Oyasu R, and Grayhack JT. 1980. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res, 40(12), 4524-4527 .PMID: 7438086.
157. Samanic C, Kogevinas M, Dosemeci M, et al. 2006. Smoking and bladder cancer in Spain: effects of Tobacco type, timing, environmental Tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15(7), 1348-1354 .PMID: 16835335.
158. Sampson JN, Wheeler WA, Yeager M, et al. 2015. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. J Natl Cancer Inst, 107(12), djv279 .PMCID: PMC4806328.
159. Sanchez-Carbayo M. 2012. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol, 33(2), 347-361 .PMID: 22274923.
160. Schned AR, Lenz P, Moore LE et al. 2012. Analysis of the distribution and temporal trends of grade and stage in urothelial bladder cancer in northern New England from 1994 to 2004. ISRN Pathol, 2012, 283-670 .PMCID: PMC3966206.
161. SEER. 2015a. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2011).
162. SEER. 2015b. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEERStat Database: Incidence-SEER 9 Regs Research Data, Nov 2014 Sub (1973-2012) Katrina/Rita Population Adjustment-Linked to County Attributes-Total US, 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
163. SEER. 2015c. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEERStat Database: Incidence-SEER 13 Regs Research Data, Nov 2014 Sub (1992-2012) Katrina/Rita Population Adjustment-Linked to County Attributes-Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
164. Shih C, Hotaling JM, Wright JL, and White E. 2013. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Urol Oncol, 31(8), 1689-1695 .PMCID: PMC3522785.
165. Siegel RL, Miller KD, and Jemal A. 2016. Cancer statistics, 2016. CA Cancer J Clin, 66(1), 7-30 .PMID: 26742998.
166. Silverman DT, Alguacil J, Rothman N, et al. 2008. Does increased urination frequency protect against bladder cancer? Int J Cancer, 123(7), 1644-1648 .PMID: 18623081.
167. Silverman DT, Devesa SS, Moore LE, and Rothman N. 2006. Bladder cancer. In: Schottenfeld D, and Fraumeni JF (Eds.), Cancer epidemiology and prevention (3rd ed., pp. 1101-1127). New York: Oxford University Press.
168. Silverman DT, Hoover RN, Albert S, and Graff KM. 1983. Occupation and cancer of the lower urinary tract in Detroit. J Natl Cancer Inst, 70(2), 237-245 .PMID: 6571931.
169. Simoneau M, LaRue H, Aboulkassim TO et al. 2000. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene, 19(54), 6317-6323 .PMID: 11175346.
170. Singh V, Jaiswal PK, and Mittal RD. 2014. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians. Urol Oncol, 32(8), 1209-1214 .PMID: 25218484.
171. Sjodahl G, Lauss M, Lovgren K, et al. 2012. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res, 18(12), 3377-3386 .PMID: 22553347.
172. Sorahan T. 2008. Bladder cancer risks in workers manufacturing chemicals for the rubber industry. Occup Med (Lond), 58(7), 496-501 .PMID: 18725381.
173. Sun JW, Zhao LG, Yang Y et al. 2015. Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One, 10(3), e0119313 .PMCID: PMC4372289.
174. Takkouche B, Regueira-Mendez C, and Montes-Martinez A. 2009. Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol, 38(6), 1512-1531 .PMID: 19755396.
175. Tang JE, Wang RJ, Zhong H, Yu B, and Chen Y. 2014. Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies. World J Surg Oncol, 12, 130 .PMCID: PMC4030017.
176. Tang W, Fu YP, Figueroa JD, et al. 2012. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet, 21(8), 1918-1930 .PMCID: PMC3313801.
177. Tao L, Day BW, Hu B, et al. 2013. Elevated 4-aminobiphenyl and 2,6-dimeth- ylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers: The Shanghai Bladder Cancer Study. Cancer Epidemiol Biomarkers Prev, 22(5), 937-945 .PMCID: PMC4065796.
178. Tao L, Xiang YB, Wang R, et al. 2010. Environmental Tobacco smoke in relation to bladder cancer risk: The Shanghai Bladder Cancer Study [corrected]. Cancer Epidemiol Biomarkers Prev, 19(12), 3087-3095 .PMCID: PMC3003610.
179. Teng CJ, Hu YW, Chen SC, et al. 2016. Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population- based study. J Natl Cancer Inst, 108(2), djv314 .PMID: 26538627.
180. The Cancer Genome Atlas Research Network. 2014. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature, 507(7492), 315-322 .PMCID: PMC3962515.
181. Tuccori M, Filion KB, Yin H, et al. 2016. Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ, 352, 11541 .PMCID: PMC4816602.
182. Turati F, Pelucchi C, Galeone C, Decarli A, and La Vecchia C. 2014. Personal hair dye use and bladder cancer: a meta-analysis. Ann Epidemiol, 24(2), 151-159 .PMID: 24342029.
183. Turesky RJ, Freeman JP, Holland RD, et al. 2003. Identification of aminobiphe- nyl derivatives in commercial hair dyes. Chem Res Toxicol, 16(9), 1162-1173 .PMID: 12971805.
184. Turner RM, Kwok CS, Chen-Turner C, et al. 2014. Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis. Br J Clin Pharmacol, 78(2), 258-273 .PMCID: PMC4137819.
185. Van Hemelrijck MJ, Michaud DS, Connolly GN, and Kabir Z. 2009. Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two metaanalyses. Cancer Epidemiol Biomarkers Prev, 18(4), 1312-1320 .PMID: 19336562.
186. Vermeulen SH, Hanum N, Grotenhuis AJ, et al. 2015. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer, 112(3), 594-600 .PMCID: PMC4453642.
187. Vieira AR, Vingeliene S, Chan DS, et al. 2015. Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis. Cancer Med, 4(1), 136-146 .PMCID: PMC4312127.
188. Villanueva CM, Cantor KP, Grimalt JO, et al. 2007. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol, 165(2), 148-156 .PMID: 17079692.
189. Villanueva CM, Cantor KP, King WD, et al. 2006. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer, 118(8), 2040-2047 .PMID: 16284957.
190. Vlaanderen J, Straif K, Ruder A, et al. 2014. Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies. Environ Health Perspect, 122(7), 661-666 .PMCID: PMC4080536.
191. Wang M, Li Z, Chu H, et al. 2016. Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12. Cancer Res, 76(11), 3277-3284.
192. Ward MH, Cantor KP, Riley D, Merkle S, and Lynch CF. 2003. Nitrate in public water supplies and risk of bladder cancer. Epidemiology, 14(2), 183-190 .PMID: 12606884.
193. Welk B, McIntyre A, Teasell R, Potter P, and Loh E. 2013. Bladder cancer in individuals with spinal cord injuries. Spinal Cord, 51(7), 516-521 .PMID: 23608811.
194. Welty CJ, Wright JL, Hotaling JM, et al. 2014. Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. Urol Oncol, 32(1), 25.e21-25 .PMCID: PMC3737375.
195. Weyer PJ, Cerhan JR, Kross BC, et al. 2001. Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women's Health Study. Epidemiology, 12(3), 327-338 .PMID: 11338313.
196. Wilhelm-Benartzi CS, Koestler DC, Houseman EA, et al. 2010. DNA meth- ylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer. Carcinogenesis, 31(11), 1972-1976 .PMCID: PMC2966555.
197. Williamson MP, Elder PA, and Knowles MA. 1994. The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosomes Cancer, 9(2), 108-118 .PMID: 7513540.
198. Wolff EM, Chihara Y, Pan F, et al. 2010. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. Cancer Res, 70(20), 8169-8178 .PMCID: PMC2955801.
199. Wolff EM, Liang G, Cortez CC, et al. 2008. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res, 68(15), 6208-6214 .PMCID: PMC2536768.
200. Worst TS, Reiner V, Gabriel U, et al. 2014. IL1RN and KRT13 Expression in bladder cancer: association with pathologic characteristics and smoking status. Adv Urol, 2014, 184-602 .PMCID: PMC4119623.
201. Wright ME, Michaud DS, Pietinen P, et al. 2005. Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland). Cancer Causes Control, 16(9), 1117-1123 .PMID: 16184478.
202. Wu JW, Cross AJ, Baris D, et al. 2012. Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States. Br J Cancer, 106(11), 1891-1898 .PMCID: PMC3364127.
203. Wu X, Ye Y, Kiemeney LA, et al. 2009. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet, 41(9), 991-995 .PMID: 19648920.
204. Wynder EL, Onderdonk J, and Mantel N. 1963. An epidemiological investigation of cancer of the bladder. Cancer, 16, 1388-1407 .PMID: 14090576.
205. Yuan X, Liu C, Wang K, et al. 2016. The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients. Oncotarget, 7(18), 25826-25835 .PMCID: PMC5041947.
206. Zeegers MP, Dorant E, Goldbohm RA, and van den Brandt PA. 2001. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control, 12(3), 231-238 .PMID: 11405328.
207. Zeegers MP, Selen RF, Kleinjans JC, Goldbohm RA, and van den Brandt PA. 2006. Nitrate intake does not influence bladder cancer risk: the Netherlands cohort study. Environ Health Perspect, 114(10), 1527-1531 .PMCID: PMC1626405.
208. Zhang H, Jiang D, and Li X. 2013. Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. PLoS One, 8(7), e70008 .PMCID: PMC3716767.
209. Zhang W, Xiang YB, Fang RR, et al. 2010. [Total fluid intake, urination frequency and risk of bladder cancer: a population-based case-control study in urban Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi, 31(10), 1120-1124 .PMID: 21162813.
210. Zhang Y, Sun Y, Chen T, et al. 2014. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population. Int J Mol Sci, 15(11), 19330-19341 .PMCID: PMC4264113.
211. Zheng YL, Amr S, Saleh DA, et al. 2012. Urinary bladder cancer risk factors in Egypt: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev, 21(3), 537-546 .PMCID: PMC3297723.
212. Zhou J, Kelsey KT, Giovannucci E, and Michaud DS. 2014. Fluid intake and risk of bladder cancer in the Nurses' Health Studies. Int J Cancer, 135(5), 1229-1237 .PMCID: PMC4213947.
213. Zhou J, Smith S, Giovannucci E, and Michaud DS. 2012. Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort. Am J Epidemiol, 175(7), 696-705 .PMCID: PMC3324431.
214. Zhou Y, Tian C, and Jia C. 2012. A dose-r esponse meta-analysis of coffee consumption and bladder cancer. Prev Med, 55(1), 14-22 .PMID: 22564775.
215. Zhu Z, Wang X, Shen Z et al. 2013. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer, 13, 310 .PMCID: PMC3699355.